A Qualitative Interview Study to Explore the Use of Adverse Event Mitigation Strategies Among Adults Receiving Amikacin Liposome Inhalation Suspension (ALIS) in Real World Settings

Authors

Juzar Ali, LSU Health Sciences Center - New OrleansFollow
J. Wu, Insmed Inc., Bridgewater, NJ
M. Hassan, Insmed Inc., Bridgewater, NJ
J. Tsai, OPEN Health, Bethesda, MD
N. Touba, OPEN Health, Bethesda, MD
K. McCarrier, OPEN Health, Bethesda, MD
M. Ballard, Insmed Inc., Bridgewater, NJ
A. Chatterjee, Insmed Inc., Bridgewater, NJ

Document Type

Conference Proceeding

Publication Date

5-1-2023

Publication Title

American Journal of Respiratory and Critical Care Medicine

Abstract

American Thoracic Society International Conference, ATS 2023, May 19 - 24, 2023, Washington DC

Volume

207

Issue

1

Comments

Abstract Number: A2971

Recommended Citation

Ali, Juzar; Wu, J.; Hassan, M.; Tsai, J.; Touba, N.; McCarrier, K.; Ballard, M.; and Chatterjee, A., "A Qualitative Interview Study to Explore the Use of Adverse Event Mitigation Strategies Among Adults Receiving Amikacin Liposome Inhalation Suspension (ALIS) in Real World Settings" (2023). School of Medicine Faculty Publications. 2650.
https://digitalscholar.lsuhsc.edu/som_facpubs/2650
10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A2971